Open Terminal →

Analyses / ORCL

ORCL Oracle Corporation As of Nov 19, 2026
$113.89

Large-cap software stock near its 52-week low. Growth and margins are solid, but valuation and insider selling keep the read mixed.

Setup: Recovery watch Confidence: low Horizon: 3-12 months Risk: elevated Category: Large Cap
🔒 Trade Plan — entry · target · stop
Entry Zone
$•••–•••
Target
$•••
Stop Loss
$•••
Risk / Reward
•.• : 1
Unlock the exact levels — free →

A free account reveals ORCL's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.

The Thesis

▲ Bull Case

Revenue growth of 10.5% and EPS growth of 24% with a 25% net margin. The stock trades 54% below its 52-week high of 250.25 and only about 4% above the 52-week low of 109.21. Forward P/E of 20.4x is not extreme for a company with these margins. If the stock holds the 109 area and reclaims the 115 prevClose, the setup could draw interest from investors who view the drawdown as overdone. Morgan Stanley's AI infrastructure spending forecast, mentioned in recent headlines, is a possible demand tailwind.

▼ Bear Case

The stock is in a steep downtrend, down about 54% from its high. Insider activity is net selling: 77 sell transactions against 47 buys, with 2.76M shares sold versus 2.45M bought. Price-to-book of 16.8x and price-to-sales of 5.2x are elevated, and price-to-free-cash-flow of 29.5x implies a free cash flow yield near 3.4%. Beta of 1.84 means moves may be amplified in a weak tape. A close below the 52-week low of 109.21 would signal further downside pressure.

Valuation

FAIRLY VALUED — score 50/100

Earnings multiples are moderate, but sales, book, and free cash flow multiples are high. Several key ratios are missing.

Technical Levels

Support · $109.21 (52-week low) · $113.27 (Day low)

Resistance · $115.00 (Previous close) · $117.44 (Day high)

Financial Health

Score 55/100. Liquidity is adequate on the provided ratios. Leverage cannot be assessed because debt-to-equity and interest coverage are missing.

Catalysts

Morgan Stanley AI infrastructure spending forecast (cited in recent headline)OngoingCould support demand expectations if spending estimates hold
Next earnings reportDate not in payloadRevenue and EPS trend versus the 10.5% revenue and 24% EPS growth readings

Risk Flags

Beta of 1.84 implies amplified moves versus the market.
Insider activity skews to selling: 77 sells vs 47 buys.
Stock is 54% below its 52-week high, with a steep downtrend.
Debt-to-equity, ROE, ROIC, RSI, and PEG are missing from the payload.
No earnings date or consensus estimates in the payload.

See ORCL's full trade plan — free

Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.

Unlock ORCL free →

Recent News

More Analyses

ORCL FAQ

Is ORCL a buy right now?

Oracle Corporation's current read is a Recovery watch setup with low confidence over a 3-12 months horizon. Valuation: FAIRLY VALUED. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.

Is ORCL overvalued?

FAIRLY VALUED (valuation score 50/100). Earnings multiples are moderate, but sales, book, and free cash flow multiples are high. Several key ratios are missing.

What are the risks of buying ORCL?

The stock is in a steep downtrend, down about 54% from its high. Insider activity is net selling: 77 sell transactions against 47 buys, with 2.76M shares sold versus 2.45M bought. Price-to-book of 16.8x and price-to-sales of 5.2x are elevated, and price-to-free-cash-flow of 29.5x implies a free cash flow yield near 3.4%. Beta of 1.84 means moves may be amplified in a weak tape. A close below the 52-week low of 109.21 would signal further downside pressure.